Using MALDI-TOF mass spectrometry in peripheral blood for the follow up of newly diagnosed multiple myeloma patients treated with daratumumab-based combination therapy

Marion Eveillard, Neha Korde, Amanda Ciardiello, Benjamin Diamond, Alexander M. Lesokhin, Sham Mailankody, Eric L. Smith, Hani Hassoun, Malin Hultcrantz, Urvi A. Shah, Sydney X. Lu, Meghan Salcedo, Kelly Werner, Jenna Rispoli, Donna Mastey, Ola Landgren, Katie Thoren